Selected research
Industry Research
Cannabigerol Gummies Industry Research Report 2026
Market perspective
The global Cannabigerol Gummies market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cannabigerol Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cannabigerol Gummies is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cannabigerol Gummies is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cannabigerol Gummies include Lazarus Naturals, Medterra CBD, Endoca, Extract Labs, NuLeaf Naturals, Neurogan, Proleve Distribution, Isodiol and CBDistillery, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cannabigerol Gummies market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cannabigerol Gummies Market by Company
Lazarus Naturals
Medterra CBD
Endoca
Extract Labs
NuLeaf Naturals
Neurogan
Proleve Distribution
Isodiol
CBDistillery
Elixinol Wellness
Joy Organics
CBD American Shaman
Steves Goods
CannaCare Health
Fab CBD
Vesl Oils
Cannabigerol Gummies Segment by Type
Full Spectrum CBG Gummies
Broad Spectrum CBG Gummies
Cannabigerol Gummies Segment by Application
Pain Relief
Anti-inflammatory
Reduce Anxiety
Other
Cannabigerol Gummies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cannabigerol Gummies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cannabigerol Gummies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cannabigerol Gummies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cannabigerol Gummies manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cannabigerol Gummies by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cannabigerol Gummies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Full Spectrum CBG Gummies
- Broad Spectrum CBG Gummies
Applications
- Pain Relief
- Anti-inflammatory
- Reduce Anxiety
- Other
Companies covered
- Lazarus Naturals
- Medterra CBD
- Endoca
- Extract Labs
- NuLeaf Naturals
- Neurogan
- Proleve Distribution
- Isodiol
- CBDistillery
- Elixinol Wellness
- Joy Organics
- CBD American Shaman
- Steves Goods
- CannaCare Health
- Fab CBD
- Vesl Oils
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cannabigerol Gummies Market Size (2021-2032)
- 2.2.2 Global Cannabigerol Gummies Sales (2021-2032)
- 2.2.3 Global Cannabigerol Gummies Market Average Price (2021-2032)
- 2.3 Cannabigerol Gummies by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Full Spectrum CBG Gummies
- 2.3.3 Broad Spectrum CBG Gummies
- 2.4 Cannabigerol Gummies by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pain Relief
- 2.4.3 Anti-inflammatory
- 2.4.4 Reduce Anxiety
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cannabigerol Gummies Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cannabigerol Gummies Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Cannabigerol Gummies Revenue of Manufacturers (2021-2026)
- 3.4 Global Cannabigerol Gummies Average Price by Manufacturers (2021-2026)
- 3.5 Global Cannabigerol Gummies Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cannabigerol Gummies, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cannabigerol Gummies, Product Type & Application
- 3.8 Global Manufacturers of Cannabigerol Gummies, Established Date
- 3.9 Global Cannabigerol Gummies Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Lazarus Naturals
- 4.1.1 Lazarus Naturals Company Information
- 4.1.2 Lazarus Naturals Business Overview
- 4.1.3 Lazarus Naturals Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Lazarus Naturals Cannabigerol Gummies Product Portfolio
- 4.1.5 Lazarus Naturals Recent Developments
- 4.2 Medterra CBD
- 4.2.1 Medterra CBD Company Information
- 4.2.2 Medterra CBD Business Overview
- 4.2.3 Medterra CBD Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Medterra CBD Cannabigerol Gummies Product Portfolio
- 4.2.5 Medterra CBD Recent Developments
- 4.3 Endoca
- 4.3.1 Endoca Company Information
- 4.3.2 Endoca Business Overview
- 4.3.3 Endoca Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Endoca Cannabigerol Gummies Product Portfolio
- 4.3.5 Endoca Recent Developments
- 4.4 Extract Labs
- 4.4.1 Extract Labs Company Information
- 4.4.2 Extract Labs Business Overview
- 4.4.3 Extract Labs Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Extract Labs Cannabigerol Gummies Product Portfolio
- 4.4.5 Extract Labs Recent Developments
- 4.5 NuLeaf Naturals
- 4.5.1 NuLeaf Naturals Company Information
- 4.5.2 NuLeaf Naturals Business Overview
- 4.5.3 NuLeaf Naturals Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 NuLeaf Naturals Cannabigerol Gummies Product Portfolio
- 4.5.5 NuLeaf Naturals Recent Developments
- 4.6 Neurogan
- 4.6.1 Neurogan Company Information
- 4.6.2 Neurogan Business Overview
- 4.6.3 Neurogan Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Neurogan Cannabigerol Gummies Product Portfolio
- 4.6.5 Neurogan Recent Developments
- 4.7 Proleve Distribution
- 4.7.1 Proleve Distribution Company Information
- 4.7.2 Proleve Distribution Business Overview
- 4.7.3 Proleve Distribution Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Proleve Distribution Cannabigerol Gummies Product Portfolio
- 4.7.5 Proleve Distribution Recent Developments
- 4.8 Isodiol
- 4.8.1 Isodiol Company Information
- 4.8.2 Isodiol Business Overview
- 4.8.3 Isodiol Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Isodiol Cannabigerol Gummies Product Portfolio
- 4.8.5 Isodiol Recent Developments
- 4.9 CBDistillery
- 4.9.1 CBDistillery Company Information
- 4.9.2 CBDistillery Business Overview
- 4.9.3 CBDistillery Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 CBDistillery Cannabigerol Gummies Product Portfolio
- 4.9.5 CBDistillery Recent Developments
- 4.10 Elixinol Wellness
- 4.10.1 Elixinol Wellness Company Information
- 4.10.2 Elixinol Wellness Business Overview
- 4.10.3 Elixinol Wellness Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Elixinol Wellness Cannabigerol Gummies Product Portfolio
- 4.10.5 Elixinol Wellness Recent Developments
- 4.11 Joy Organics
- 4.11.1 Joy Organics Company Information
- 4.11.2 Joy Organics Business Overview
- 4.11.3 Joy Organics Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Joy Organics Cannabigerol Gummies Product Portfolio
- 4.11.5 Joy Organics Recent Developments
- 4.12 CBD American Shaman
- 4.12.1 CBD American Shaman Company Information
- 4.12.2 CBD American Shaman Business Overview
- 4.12.3 CBD American Shaman Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 CBD American Shaman Cannabigerol Gummies Product Portfolio
- 4.12.5 CBD American Shaman Recent Developments
- 4.13 Steves Goods
- 4.13.1 Steves Goods Company Information
- 4.13.2 Steves Goods Business Overview
- 4.13.3 Steves Goods Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Steves Goods Cannabigerol Gummies Product Portfolio
- 4.13.5 Steves Goods Recent Developments
- 4.14 CannaCare Health
- 4.14.1 CannaCare Health Company Information
- 4.14.2 CannaCare Health Business Overview
- 4.14.3 CannaCare Health Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 CannaCare Health Cannabigerol Gummies Product Portfolio
- 4.14.5 CannaCare Health Recent Developments
- 4.15 Fab CBD
- 4.15.1 Fab CBD Company Information
- 4.15.2 Fab CBD Business Overview
- 4.15.3 Fab CBD Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Fab CBD Cannabigerol Gummies Product Portfolio
- 4.15.5 Fab CBD Recent Developments
- 4.16 Vesl Oils
- 4.16.1 Vesl Oils Company Information
- 4.16.2 Vesl Oils Business Overview
- 4.16.3 Vesl Oils Cannabigerol Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Vesl Oils Cannabigerol Gummies Product Portfolio
- 4.16.5 Vesl Oils Recent Developments
5 Global Cannabigerol Gummies Market Scenario by Region
- 5.1 Global Cannabigerol Gummies Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cannabigerol Gummies Sales by Region: 2021-2032
- 5.2.1 Global Cannabigerol Gummies Sales by Region: 2021-2026
- 5.2.2 Global Cannabigerol Gummies Sales by Region: 2027-2032
- 5.3 Global Cannabigerol Gummies Revenue by Region: 2021-2032
- 5.3.1 Global Cannabigerol Gummies Revenue by Region: 2021-2026
- 5.3.2 Global Cannabigerol Gummies Revenue by Region: 2027-2032
- 5.4 North America Cannabigerol Gummies Market Facts & Figures by Country
- 5.4.1 North America Cannabigerol Gummies Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cannabigerol Gummies Sales by Country (2021-2032)
- 5.4.3 North America Cannabigerol Gummies Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cannabigerol Gummies Market Facts & Figures by Country
- 5.5.1 Europe Cannabigerol Gummies Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cannabigerol Gummies Sales by Country (2021-2032)
- 5.5.3 Europe Cannabigerol Gummies Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cannabigerol Gummies Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cannabigerol Gummies Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cannabigerol Gummies Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cannabigerol Gummies Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cannabigerol Gummies Market Facts & Figures by Country
- 5.7.1 South America Cannabigerol Gummies Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cannabigerol Gummies Sales by Country (2021-2032)
- 5.7.3 South America Cannabigerol Gummies Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Cannabigerol Gummies Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cannabigerol Gummies Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cannabigerol Gummies Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cannabigerol Gummies Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cannabigerol Gummies Sales by Type (2021-2032)
- 6.1.1 Global Cannabigerol Gummies Sales by Type (2021-2032) & (t)
- 6.1.2 Global Cannabigerol Gummies Sales Market Share by Type (2021-2032)
- 6.2 Global Cannabigerol Gummies Revenue by Type (2021-2032)
- 6.2.1 Global Cannabigerol Gummies Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cannabigerol Gummies Revenue Market Share by Type (2021-2032)
- 6.3 Global Cannabigerol Gummies Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cannabigerol Gummies Sales by Application (2021-2032)
- 7.1.1 Global Cannabigerol Gummies Sales by Application (2021-2032) & (t)
- 7.1.2 Global Cannabigerol Gummies Sales Market Share by Application (2021-2032)
- 7.2 Global Cannabigerol Gummies Revenue by Application (2021-2032)
- 7.2.1 Global Cannabigerol Gummies Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cannabigerol Gummies Revenue Market Share by Application (2021-2032)
- 7.3 Global Cannabigerol Gummies Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cannabigerol Gummies Value Chain Analysis
- 8.1.1 Cannabigerol Gummies Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cannabigerol Gummies Production Mode & Process
- 8.2 Cannabigerol Gummies Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cannabigerol Gummies Distributors
- 8.2.3 Cannabigerol Gummies Customers
9 Global Cannabigerol Gummies Analyzing Market Dynamics
- 9.1 Cannabigerol Gummies Industry Trends
- 9.2 Cannabigerol Gummies Industry Drivers
- 9.3 Cannabigerol Gummies Industry Opportunities and Challenges
- 9.4 Cannabigerol Gummies Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst